In particular, ASU has shown efficacy against periodontal disease by modulating the expression of transforming growth factor beta 1 (TGF-β1), TGF-β2, and bone morphogenetic protein 2 (BMP-2) [206]. Here, TGFB1 is linked to periodontal disorder.